The Use of Magnesium Sulfate in Prevention of Postoperative Shivering
- Conditions
- shivering.Other complications of anaesthesia
- Registration Number
- IRCT2017012432099N3
- Lead Sponsor
- Deputy for Research at Gonabad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria: The patients must be between 20-80 years old; be willing to participate in the study; complete the informed consent form; not have cardiac nor pulmonary diseases; not have thyroid dysfunction; not be allergic to the prescribed medicines; not suffer from Parkinson’s disease; dysautonomia nor rhinod syndrome; not drink alcohol; not use vasodilator; have a central temperature of 36.5 degrees centigrade before the onset of operation; not suffer from neurologic nor psychological disorders; and have normal functioning of the kidneys and normal output of urine.
The occurrence of any kind of clinical outcome or condition that makes the postoperative evaluation impossible; having central temperature less than 36.5 degrees centigrade or higher than 38 during operation; and requiring transfusion during surgery.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Shivering. Timepoint: ?After the intervention, immediately after the infusion of magnesium sulfate, during the operation and one hour after the end of surgery. Method of measurement: Based on the observed measure.
- Secondary Outcome Measures
Name Time Method Blood Pressure. Timepoint: After the intervention every fifteen minutes during the operation and as long as one hour after the operation. Method of measurement: Based on mercury mm using sphygmomanometer.